A randomised controlled trial comparing two temporising management strategies, one with and one without plasma volume expansion, for severe and early onset pre-eclampsia

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 112, Issue 10, 2005, Pages 1358-1368

  Ganzevoort, Wessel ^a   Rep, Annelies ^b   Bonsel, Gouke J ^a   Fetter, Willem P F ^b   Van Sonderen, Loekie ^a   De Vries, Johanna I P ^b   Wolf, Hans ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; DIHYDRALAZINE; HEMOGLOBIN; HETASTARCH; INFUSION FLUID; KETANSERIN; LABETALOL; MAGNESIUM SULFATE; METHYLDOPA; NIFEDIPINE; SODIUM CHLORIDE; ANTIHYPERTENSIVE AGENT; PLASMA SUBSTITUTE;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CESAREAN SECTION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; FEMALE; FETUS; GESTATIONAL AGE; HELLP SYNDROME; HEMOGLOBIN DETERMINATION; HOSPITAL ADMISSION; HUMAN; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MATERNAL MORBIDITY; NERVOUS SYSTEM DEVELOPMENT; NETHERLANDS; NEWBORN; NEWBORN MORBIDITY; OXYGEN THERAPY; PERINATAL DEATH; PLASMA VOLUME; PREECLAMPSIA; PRIORITY JOURNAL; PROLONGED PREGNANCY; RANDOMIZED CONTROLLED TRIAL; TERM BIRTH; BLOOD PRESSURE; BODY WEIGHT; FLUID THERAPY; METHODOLOGY; MULTICENTER STUDY; PHYSIOLOGY; PREGNANCY; PREGNANCY OUTCOME;

ADULT; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BODY WEIGHT; FEMALE; FLUID THERAPY; HETASTARCH; HUMANS; PLASMA SUBSTITUTES; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME;

EID: 32944465427     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2005.00687.x     Document Type: Article

References (44)

1. Murphy DJ, Stirrat GM. Mortality and morbidity associated with early-onset pre-eclampsia. Hypertens Pregnancy 2000 19 : 221 231.
2. Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 1993 169 : 1000 1006.
3. Sibai BM, Mercer BM, Schiff E, Friedman SA. Aggressive versus expectant management of severe pre-eclampsia at 28 to 32 weeks' gestation: a randomized controlled trial. Am J Obstet Gynecol 1994 171 : 818 822.
4. Odendaal HJ, Pattinson RC, Bam R, Grove D, Kotze TJ. Aggressive or expectant management for patients with severe pre-eclampsia between 28-34 weeks' gestation: a randomized controlled trial. Obstet Gynecol 1990 76 : 1070 1075.
5. van Pampus MG, Wolf H, Westenberg SM, van der Post JA, Bonsel GJ, Treffers PE. Maternal and perinatal outcome after expectant management of the HELLP syndrome compared with pre-eclampsia without HELLP syndrome. Eur J Obstet Gynecol Reprod Biol 1998 76 : 31 36.
6. Hall DR, Odendaal HJ, Kirsten GF, Smith J, Grove D. Expectant management of early onset, severe pre-eclampsia: perinatal outcome. BJOG 2000 107 : 1258 1264.
7. Hall DR, Odendaal HJ, Steyn DW, Grove D. Expectant management of early onset, severe pre-eclampsia: maternal outcome. BJOG 2000 107 : 1252 1257.
8. Cloeren SE, Lippert TH. Effect of plasma expanders in toxemia of pregnancy. N Engl J Med 1972 287 : 1356 1357.
9. Visser W, van Pampus MG, Treffers PE, Wallenburg HC. Perinatal results of hemodynamic and conservative temporizing treatment in severe pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 1994 53 : 175 181.
10. Hubner F, Sander C. Dopplersonographische Befunde unter Hamodilution mit Hydroxyathylstarke bei intrauteriner fetaler Retardierung. Doppler ultrasound findings in hemodilution with hydroxyethyl starch in intrauterine fetal retardation. Geburtshilfe Frauenheilkd 1995 55 : 87 92.
11. Karsdorp VH, van Vugt JM, Dekker GA, van Geijn HP. Reappearance of end-diastolic velocities in the umbilical artery following maternal volume expansion: a preliminary study. Obstet Gynecol 1992 80 : 679 683.
12. Heilmann L. Klinische Ergebnisse nach Hamodilution mit Hydroxyathylstarke in der Schwangerschaft. Clinical results after hemodilution with hydroxyethyl starch in pregnancy. Z Geburtshilfe Perinatol 1989 193 : 219 225.
13. Duley L, Williams J, Henderson-Smart DJ. Plasma volume expansion for treatment of women with pre-eclampsia. Cochrane Database Syst Rev 2000 124 : CD001805.
14. Young PF, Leighton NA, Jones PW, Anthony J, Johanson RB. Fluid management in severe pre-eclampsia (VESPA): survey of members of ISSHP. Hypertens Pregnancy 2000 19 : 249 259.
15. Gulmezoglu AM, Hofmeyr GJ. Plasma volume expansion for suspected impaired fetal growth. Cochrane Database Syst Rev 2000 : CD000167.
16. Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988 158 : 892 898.
17. Sibai BM. The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing Am J Obstet Gynecol 1990 162 : 311 316.
18. Gardosi J, Chang A, Kalyan B, Sahota D, Symonds EM. Customised antenatal growth charts. Lancet 1992 339 : 283 287.
19. Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics 1988 82 : 527 532.
20. Volpe JJ. Intraventricular hemorrhage and brain injury in the premature infant. Diagnosis, prognosis, and prevention. Clin Perinatol 1989 16 : 387 411.
21. De Vries LS, Eken P, Dubowitz LM. The spectrum of leukomalacia using cranial ultrasound. Behav Brain Res 1992 49 : 1 6.
22. Walsh MC, Kliegman RM. Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am 1986 33 : 179 201.
23. Hadlock FP, Harrist RB, Sharman RS, Deter RL, Park SK. Estimation of fetal weight with the use of head, body, and femur measurements - a prospective study. Am J Obstet Gynecol 1985 151 : 333 337.
24. Prechtl HFR, Beintema D. The Neurological Examination of the Full-Term Newborn Infant. London : Spastics International Medical Publications/William Heinemann Medical Books, 1964.
25. Touwen BC, Huisjes HJ, Jurgens-van der Zee AD, Bierman-van Eendenburg ME, Smrkovsky M, Olinga AA. Obstetrical condition and neonatal neurological morbidity. An analysis with the help of the optimality concept. Early Hum Dev 1980 4 : 207 228.
26. Maas YG, Mirmiran M, Hart AA, Koppe JG, Ariagno RL, Spekreijse H. Predictive value of neonatal neurological tests for developmental outcome of preterm infants. J Pediatr 2000 137 : 100 106.
27. Olah KS, Redman CW, Gee H. Management of severe, early pre-eclampsia: is conservative management justified Eur J Obstet Gynecol Reprod Biol 1993 51 : 175 180.
28. Visser W, Wallenburg HC. Maternal and perinatal outcome of temporizing management in 254 consecutive patients with severe pre-eclampsia remote from term. Eur J Obstet Gynecol Reprod Biol 1995 63 : 147 154.
29. Scherjon SA, Smolders-DeHaas H, Kok JH, Zondervan HA. The Brain-sparing effect. Antenatal cerebral Doppler findings in relation to neurologic outcome in very preterm infants. Am J Obstet Gynecol 1993 169 : 169 175.
30. Friedman SA, Schiff E, Kao L, Sibai BM. Neonatal outcome after preterm delivery for pre-eclampsia. Am J Obstet Gynecol 1995 172 : 1785 1788.
31. Vigil-De Gracia P, Montufar-Rueda C, Ruiz J. Expectant management of severe pre-eclampsia and pre-eclampsia superimposed on chronic hypertension between 24 and 34 weeks' gestation. Eur J Obstet Gynecol Reprod Biol 2003 107 : 24 27.
32. Schaap AH, Wolf H, Bruinse HW, et al. Fetal distress due to placental insufficiency at 26 through 31 weeks: a comparison between an active and a more conservative management. Eur J Obstet Gynecol Reprod Biol 1996 70 : 61 68.
33. Levene MI, Fawer CL, Lamont RF. Risk factors in the development of intraventricular haemorrhage in the preterm neonate. Arch Dis Child 1982 57 : 410 417.
34. Thornton JG, Hornbuckle J, Vail A, Spiegelhalter DJ, Levene M. Infant wellbeing at 2 years of age in the Growth Restriction Intervention Trial (GRIT): multicentred randomised controlled trial. Lancet 2004 364 : 513 520.
35. The GRIT study group. A randomised trial of timed delivery for the compromised preterm fetus: short term outcomes and Bayesian interpretation. BJOG 2003 110 : 27 32.
36. Withagen MI, Visser W, Wallenburg HC. Neonatal outcome of temporizing treatment in early-onset pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 2001 94 : 211 215.
37. Belfort M, Uys P, Dommisse J, Davey DA. Haemodynamic changes in gestational proteinuric hypertension: the effects of rapid volume expansion and vasodilator therapy. Br J Obstet Gynaecol 1989 96 : 634 641.
38. Lowe SA, Hetmanski DJ, Macdonald I, Pipkin FB, Rubin PC. Intravenous volume expansion therapy in pregnancy-induced hypertension: the role of vasoactive hormones. Hypertens Pregnancy 1993 12 : 139 151.
39. Sehgal NN, Hitt JR. Plasma volume expansion in the treatment of pre-eclampsia. Am J Obstet Gynecol 1980 138 : 165 168.
40. Heilmann L, Gerhold S, von Tempelhoff GF, Pollow K. The role of intravenous volume expansion in moderate pre-eclampsia. Clin Hemorheol Microcirc 2001 25 : 83 89.
41. Sandham JD, Hull RD, Brant RF, et al. A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. N Engl J Med 2003 348 : 5 14.
42. Duley L, Henderson-Smart DJ. Drugs for rapid treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev 2000 : CD001449.
43. Abalos E, Duley L, Steyn DW, Henderson-Smart DJ. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy [Cochrane review]. Cochrane Database Syst Rev 2001 2 : CD002252.
44. Samsom JF, de Groot L, Bezemer PD, Lafeber HN, Fetter WP. Muscle power development during the first year of life predicts neuromotor behaviour at 7 years in preterm born high-risk infants. Early Hum Dev 2002 68 : 103 118.